1. Synthesis and biological evaluation of novel isobenzofuran-1(3H)-one derivatives as antidepressant agents.
- Author
-
Tao L, Yao C, Wang S, Ye Y, Tu Z, Jiang X, Xu L, Shan L, Liu Z, and Yu P
- Subjects
- Animals, Mice, Structure-Activity Relationship, Male, Depression drug therapy, Benzofurans chemical synthesis, Benzofurans pharmacology, Benzofurans chemistry, Molecular Structure, Hippocampus drug effects, Hippocampus metabolism, Selective Serotonin Reuptake Inhibitors chemical synthesis, Selective Serotonin Reuptake Inhibitors pharmacology, Selective Serotonin Reuptake Inhibitors chemistry, Humans, Dose-Response Relationship, Drug, Antidepressive Agents chemical synthesis, Antidepressive Agents pharmacology, Antidepressive Agents chemistry
- Abstract
A series of novel isobenzofuran-1(3H)-one derivatives were designed and synthesized as antidepressants. Firstly, the serotonin reuptake inhibition of these compounds was tested in vitro, and most of them exhibited activity. Particularly, compounds 9d, 10a, and 10c demonstrated superior inhibitory effects and possibly avoided addiction via the μ-opioid receptor and CCK-B receptor. Secondly, the antidepressant effect of compound 10a was evaluated using chronic restraint stress (CRS)-induced mice. The results showed that compound 10a significantly improved CRS-induced depression-like behavior by increasing the neurotransmitters 5-HT in the cortex and THP2 expression in the hippocampus. Thirdly, compound 10a was further investigated and found to enhance CRS-induced hippocampal neuron damage recovery and elevate the expression of synaptic-associated proteins such as BDNF, TrkB, PSD95, and Spinophilin in CRS-induced mice. These findings suggested that novel isobenzofuran-1(3H)-one derivative showed efficacy in treating depression, with compound 10a emerging as a potential lead compound warranting further investigation., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF